Finanzen von MiniMed Group Inc (MMED)MMEDMiniMed Group Inc

MiniMed Group Inc (MMED) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is CGM, accounting for 50.2% of total sales, equivalent to $420.00M. Other significant revenue streams include Consumables and Pumps. Understanding this composition is critical for investors evaluating how MMED navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, MiniMed Group Inc maintains a gross margin of 55.16%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 45.43%, while the net margin is 0.00%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively MMED converts its operational activities into shareholder value.

In the context of the broader market, MMED competes directly with industry leaders such as SHC and STVN. With a market capitalization of $4.92B, it holds a significant position in the sector. When comparing efficiency, MMED's gross margin of 55.16% stands against SHC's 54.44% and STVN's 29.51%. Such benchmarking helps identify whether MiniMed Group Inc is trading at a premium or discount relative to its financial performance.

MiniMed's total revenue has shown an upward trend, reaching 837 million USD in Q4 2026, but the net income remains negative, with a loss of -185 million USD in Q4 2026. The gross margin is relatively stable at around 57%, but the net margin is concerningly low at -22.10%.